For more info visit www.newsinfusion.com GARDASIL Now Approved for Use in both Males and Females in the U.S. GARDASIL is not recommended for use in pregnant women. The most common adverse reaction was headache. Common adverse reactions that were observed among recipients of GARDASIL at a frequency of at least 1.0 percent and greater than placebo were: fever, nausea, dizziness; and injection-site pain, swelling, erythema, pruritus and bruising. The Prescribing Information and Patient Product Information for GARDASIL is attached and available at: http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf
